| Biological Information | |
|---|---|
| Background Information: | CCL13 is a cytokine protein involved in the induction of chemotaxis in monocytes, as well as eosinophils, T lymphocytes, and basophils, by acting as an agonist for cell surface receptors like CCR2, CCR3, and CCR5. It plays a role in leukocyte accumulation during inflammation. Activity of this protein has been linked to asthma and atopic dermatitis, and can be induced by the inflammatory cytokines, including interleukin-1 and TNF-α. Provided as 5 μg of dry powder alongside reconstitution buffer. |
| Target Class: | Cytokine |
| Family: | Chemokine |
| Target Name: | CCL13 |
| Usage | |
| Product Type: | Recombinant Proteins |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Recombinant Human CCL13
Recombinant Human CCL13 is an agonist for CCR2, CCR3, and CCR5. This product is provided as 5μg of dry powder alongside reconstitution buffer.
Datasheets
92-1003 Datasheet
View Document